EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Antimicrobial resistance profiles of Escherichia coli isolated from clinical and environmental samples: findings and implications

Maisa Kasanga, Doreen Mainza Shempela, Victor Daka iD, Mark J Mwikisa, Jay Sikalima, Duncan Chanda iD, Steward Mudenda iD

JAC-Antimicrobial Resistance · 05.03.2024 · 6 (2)

DOI: 10.1093/jacamr/dlae061 ↗

Kurz gefasst

Fachartikel in der Zeitschrift JAC-Antimicrobial Resistance, online erschienen am 27.04.2024. Verfasst von Maisa Kasanga und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Epidemiology and Biostatistics, School of Public Health, Zhengzhou University, Zhengzhou, China. Die Arbeit wurde bisher 45-mal zitiert (Crossref) und nennt 132 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: AMR, AMS.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The overuse and misuse of antimicrobials has worsened the problem of antimicrobial resistance (AMR) globally. This study investigated the AMR profiles of Escherichia coli isolated from clinical and environmental samples in Lusaka, Zambia.

Methods

This was a cross-sectional study conducted from February 2023 to June 2023 using 450 samples. VITEK® 2 Compact was used to identify E. coli and perform antimicrobial susceptibility testing. Data analysis was done using WHONET 2022 and SPSS version 25.0.

Results

Of the 450 samples, 66.7% (n = 300) were clinical samples, whereas 33.3% (n = 150) were environmental samples. Overall, 47.8% (n = 215) (37.8% clinical and 10% environmental) tested positive for E. coli. Of the 215 E. coli isolates, 66.5% were MDR and 42.8% were ESBL-producers. Most isolates were resistant to ampicillin (81.4%), sulfamethoxazole/trimethoprim (70.7%), ciprofloxacin (67.9%), levofloxacin (64.6%), ceftriaxone (62.3%) and cefuroxime (62%). Intriguingly, E. coli isolates were highly susceptible to amikacin (100%), imipenem (99.5%), nitrofurantoin (89.3%), ceftolozane/tazobactam (82%) and gentamicin (72.1%).

Conclusions

This study found a high resistance of E. coli to some antibiotics that are commonly used in humans. The isolation of MDR and ESBL-producing E. coli is a public health concern and requires urgent action. Therefore, there is a need to instigate and strengthen interventional strategies including antimicrobial stewardship programmes to combat AMR in Zambia.

Autor:innen und Institutionen

  • Department of Epidemiology and Biostatistics, School of Public Health, Zhengzhou University, Zhengzhou, China.
  • Laboratory Department, Churches Health Association of Zambia, CHAZ COMPLEX Meanwood Drive (off Great East Road), Plot No. 2882/B/5/10, P.O. Box 34511, JC9H+VFF, Lusaka, Zambia.
  • Public Health Department, Michael Chilufya Sata School of Medicine, Copperbelt University, Ndola, Zambia.
  • Department of Pathology and Microbiology, Lusaka Trust Hospital, Plot 2191, H8CC+52F, Nsumbu Rd, Woodlands, Lusaka, Zambia.
  • Adult Centre of Excellence, University Teaching Hospital, Lusaka, Zambia.
  • Department of Pharmacy, School of Health Sciences, University of Zambia, Lusaka, Zambia.

ORCID-Profile: Victor Daka, Duncan Chanda, Steward Mudenda

Förderung

  • AMR
  • AMS

Zitieren

APA

Kasanga, M., Shempela, D. M., Daka, V., Mwikisa, M. J., Sikalima, J., Chanda, D., & Mudenda, S. (2024). Antimicrobial resistance profiles of Escherichia coli isolated from clinical and environmental samples: findings and implications. JAC-Antimicrobial Resistance, 6(2). https://doi.org/10.1093/jacamr/dlae061

Vancouver

Kasanga M, Shempela DM, Daka V, Mwikisa MJ, Sikalima J, Chanda D, et al. Antimicrobial resistance profiles of Escherichia coli isolated from clinical and environmental samples: findings and implications. JAC-Antimicrobial Resistance. 2024;6(2). doi:10.1093/jacamr/dlae061

BibTeX
@article{Kasanga2024,
  author = {Kasanga, Maisa and Shempela, Doreen Mainza and Daka, Victor and Mwikisa, Mark J and Sikalima, Jay and Chanda, Duncan and Mudenda, Steward},
  title = {Antimicrobial resistance profiles of Escherichia coli isolated from clinical and environmental samples: findings and implications},
  journal = {JAC-Antimicrobial Resistance},
  year = {2024},
  volume = {6},
  number = {2},
  doi = {10.1093/jacamr/dlae061}
}
Kostenlos starten →